Abstract
This study provides a comprehensive update on the prevalence of Hepatitis B virus (HBV) among pregnant women in China. Analyzing data from 2016 to 2021, the meta-analysis reveals an overall infection rate of 6.64%, with significant regional variations and high rates of HBeAg positivity. The findings underscore the ongoing challenge of mother-to-child transmission (MTCT) and the need for targeted clinical interventions. (PROSPERO identifier: CRD42021289123).
Introduction
Hepatitis B remains a major public health challenge in China, which bears the world's largest disease burden for the virus. A critical bottleneck in the World Health Organization's goal to eliminate HBV by 2030 is mother-to-child transmission (MTCT). To effectively block this pathway, policymakers and clinicians require precise, up-to-date epidemiological data. This paper synthesizes recent data to map the current landscape of HBV among pregnant Chinese women, identifying high-risk regions and demographic trends to inform screening and vaccination strategies.
Methodology
The researchers conducted a systematic review and meta-analysis following PRISMA guidelines. They queried six major databases (PubMed, EMbase, Cochrane, CNKI, Wan-Fang, and VIP) for studies published between January 2016 and June 2021. The analysis focused on cohort and cross-sectional studies reporting HBsAg (Hepatitis B surface antigen) positivity in pregnant women across China. Data from 42 studies, encompassing a total sample size of 4,007,518 cases across 20 provinces, were synthesized using a random-effects model to account for heterogeneity.
Key Results and Prevalence
The meta-analysis determined an overall HBV prevalence of 6.64% (95% CI: 5.72–7.57%) among pregnant women in China. This rate classifies the situation as "intermediate endemic." While this represents progress since the 1990s, it remains significantly higher than the WHO's 0.1% target for children.
A critical finding is the "infectivity gap": among HBsAg-positive women, 25.80% were also HBeAg-positive, a marker of high viral replication. Furthermore, 26.73% of HBsAg-positive women exhibited high HBV DNA levels (>2 × 10⁵ IU/ml), indicating a substantial risk of transmission to newborns without antiviral prophylaxis.
Geographic and Demographic Trends
The study highlighted significant geographic disparities in HBV prevalence. The highest rates were found in Western China (7.15%), followed by Eastern China (6.63%), and the lowest in Central China (5.23%).
Demographically, prevalence generally increased with age. This likely reflects a "cohort effect," where older pregnant women were born before the full implementation of universal infant HBV vaccination programs in China. Interestingly, regions with higher economic levels showed slightly higher prevalence in some subgroups, potentially due to more robust screening and reporting or migration patterns.
Limitations and Future Directions
Despite its scale, the study faced limitations, including incomplete geographic coverage (missing data from provinces like Xinjiang and Beijing) and potential publication bias. The impact of factors like education and urban-rural residence remains controversial due to conflicting data. Future research should focus on the drivers of regional disparities and the efficacy of MTCT blocking methods in high-prevalence areas to reach the 2030 elimination goals.
Summary updated